Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Impact of elranatamab on quality of life: Patient‐reported outcomes from MagnetisMM‐3
Impact of elranatamab on quality of life: Patient‐reported outcomes from MagnetisMM‐3
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Mohamad Mohty
,
Nizar J. Bahlis
,
Ajay K. Nooka
,
Marco DiBonaventura
,
Jinma Ren
,
Umberto Conte
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
British Journal of Haematology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Induction prior to autologous haematopoietic cell transplantation in multiple myeloma
by: Mohamad Mohty, et al.
Published: (2024)
Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 study
by: Michael H. Tomasson, et al.
Published: (2024)
Severe cytopenia after chimeric antigen receptor‐T cell driven by large granular lymphocytes and responsive to steroids
by: Antoine Capes, et al.
Published: (2024)
T‐cell‐based immunotherapies for human immunodeficiency virus patient with relapsed/refractory multiple myeloma: A success story from our clinic
by: S. Moraru, et al.
Published: (2025)
Patient‐reported health‐related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib–rituximab versus fludarabine–cyclophosphamide–rituximab
by: David J. Allsup, et al.
Published: (2026)
